Moclobemide
Alternative Names: Aurorix; Manerix; RO 11; RO 111163Latest Information Update: 05 Apr 2022
At a glance
- Originator Roche
- Developer Sumitomo Pharma
- Class Antidepressants; Benzamides; Chlorobenzenes; Morpholines; Small molecules
- Mechanism of Action Monoamine oxidase A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Major depressive disorder